ISOVUE 300 612 mg/mL

ISOVUE 300 612 mg/mL is an iodinated contrast media used for diagnostic imaging procedures. This intravenous solution enhances visibility in X-ray and CT scans, aiding in accurate diagnosis. Ideal for medical professionals seeking reliable contrast agents.

ISOVUE 300 612 mg/mL is primarily used as a contrast medium for various diagnostic imaging techniques, including computed tomography (CT) scans and angiography. It helps to enhance the visibility of internal structures, making it easier for healthcare providers to identify abnormalities. This solution is often utilized in procedures requiring detailed imaging of blood vessels, organs, and tissues.

When administered intravenously, ISOVUE 300 612 mg/mL can cause temporary side effects such as warmth, flushing, or a metallic taste in the mouth. Some individuals may experience mild nausea or dizziness. These effects are generally short-lived and subside quickly. Severe reactions are rare but should be reported to a healthcare provider immediately.

ISOVUE 300 612 mg/mL should be handled with care and administered by trained medical professionals. It is essential to inform your healthcare provider about any allergies or pre-existing conditions before use. Proper storage and handling procedures should be followed to maintain the integrity of the solution. Always use sterile techniques when preparing and administering the injection.

ISOVUE 300 612 mg/mL may interact with certain medications or substances, including other contrast agents and medications that affect kidney function. It is important to disclose all current medications to your healthcare provider before undergoing any diagnostic procedure involving this contrast medium. Alcohol and certain foods may also influence the body's response to the contrast agent.